Bayer to present new Kerendia™ (finerenone) data from comprehensive clinical trial program in chronic kidney disease and type 2 diabetes
Berlin, May 17, 2022, - Bayer will present new renal and cardiovascular data from the comprehensive Kerendia™ (finerenone) clinical trial ...
Read moreDetails